Blood Gas Analyzer Market Outlook:
Blood Gas Analyzer Market size was valued at USD 674.96 million in 2025 and is set to exceed USD 1.08 billion by 2035, expanding at over 4.8% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of blood gas analyzer is estimated at USD 704.12 million.
The whole blood specimen's blood gas, pH, electrolyte, and certain metabolites are measured using blood gas analyzers. The main reasons propelling the market during this time are rapid urbanization, changing lifestyles, unhealthy eating habits, blood vessel bleeding, chronic illnesses, and technological improvements in the device. These analyzers are perfect for point-of-care testing and have several benefits for patients receiving critical care. For example, as of September 2021, 1,260,000 new and recurrent coronary attacks occur annually, according to the National Heart, Lung, and Blood Institute's Atherosclerotic Risk in Communities study and Cardiovascular Health Study; approximately 37% of individuals who experience a coronary attack in a given year pass away from it.
The global market for blood gas analyzers could see substantial growth if telemetry systems are integrated with blood gas analyzers. A growing trend in healthcare is remote patient monitoring, and using telemetry and blood gas analyzers together enables continuous patient monitoring from a distance. This can assist in resolving several enduring issues. Blood gas analyzers become much more useful when they can be integrated with telemetry; this opens up new clinical applications and paves the way for increased use of the devices in various care settings in the years to come. If companies in the blood gas analyzers market adjust to include these quickly developing connectivity capabilities, this offers them great growth prospects.
